Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Proposed 'vascular frailty' framework links vascular aging and frailty in chronic kidney disease

This review proposes 'vascular frailty' as a conceptual framework connecting vascular aging, loss of vascular reserve and systemic vulnerability in chronic kidney disease; it is not a validated subtype, and its added prognostic and clinical value remains to be established. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The review describes chronic kidney disease as increasingly recognized as a model of accelerated biological aging with premature cardiovascular disease and frailty. [1]

  2. The authors propose vascular frailty as a conceptual framework, not another frailty subtype, linking vascular aging, loss of vascular reserve and systemic vulnerability in CKD. [1]

  3. Emerging evidence supports feasibility of integrating vascular measures with frailty assessment, but incremental prognostic and clinical value remains to be established. [1]

The source at a glance

Study type / format
Review proposing a conceptual framework (abstract only)
Population / context
People with chronic kidney disease and other aging-related conditions, as discussed in a review.
Summary based on
Study abstract
Original publication
September 6, 2026

CKD as accelerated biological aging model

The review describes chronic kidney disease (CKD) as increasingly recognized as a model of accelerated biological aging, marked by premature cardiovascular disease and frailty. It notes that current frailty models mainly emphasize physical performance and functional decline, giving limited insight into the vascular mechanisms behind biological vulnerability. Vascular aging, in turn, is traditionally framed within cardiovascular medicine and little integrated into frailty research. The authors therefore propose vascular frailty as a unifying framework bridging geroscience, nephrology and vascular medicine.

Supporting source [1]

Proposed phenotype: structure, function and frailty assessment

The authors summarize mechanisms through which CKD accelerates vascular aging and discuss vascular reserve and vascular resilience as concepts linking vascular aging to systemic frailty. On this basis they claim that vascular frailty could be a multidimensional phenotype integrating structural vascular remodeling, functional vascular impairment and conventional frailty assessment. They highlight emerging approaches to operationalize it through vascular imaging, physiological assessment and biomarker profiling. They stress that vascular frailty is not another frailty subtype but a conceptual framework linking vascular aging, loss of vascular reserve and systemic vulnerability in CKD.

Supporting source [1]

Feasibility suggested, clinical value unproven

According to the abstract, emerging evidence supports the feasibility of combining structural and functional vascular measures with conventional frailty assessment. However, the incremental prognostic and clinical value of this approach remains to be established. The authors state that further longitudinal and interventional studies are needed to determine whether vascular frailty can contribute to risk stratification, individualized management and strategies aimed at preserving vascular resilience in CKD and other aging-related conditions. These are proposed directions, not demonstrated outcomes.

Supporting source [1]

How to interpret this

This explainer is based only on the abstract; the full text was not reviewed. The abstract reports a proposed conceptual framework and review of mechanisms, not a primary study with its own sample, follow-up or measured outcomes. Feasibility of combining vascular measures with frailty assessment is described as supported by emerging evidence, but incremental prognostic and clinical value is explicitly stated as not yet established. Whether vascular frailty improves risk stratification or management is a question for future longitudinal and interventional studies.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    model of accelerated biological aging
  2. Finding 2 ↑

    Rather than representing another frailty subtype
  3. Finding 3 ↑

    incremental prognostic and clinical value remain to

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…